140 related articles for article (PubMed ID: 8077684)
21. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
22. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma.
Mackensen A; Ferradini L; Carcelain G; Triebel F; Faure F; Viel S; Hercend T
Cancer Res; 1993 Aug; 53(15):3569-73. PubMed ID: 8339262
[TBL] [Abstract][Full Text] [Related]
23. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia.
Manz CY; Dietrich PY; Schnuriger V; Nissen C; Wodnar-Filipowicz A
Blood Cells Mol Dis; 1997; 23(1):110-22. PubMed ID: 9215756
[TBL] [Abstract][Full Text] [Related]
24. Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.
Pappas J; Jung WJ; Barda AK; Lin WL; Fincke JE; Purev E; Radu M; Gaughan J; Helm CW; Hernandez E; Freedman RS; Platsoucas CD
Cell Immunol; 2005 Apr; 234(2):81-101. PubMed ID: 16038891
[TBL] [Abstract][Full Text] [Related]
25. T-cell receptor repertoire in neuroblastoma patients.
Valteau D; Scott V; Carcelain G; Hartmann O; Escudier B; Hercend T; Triebel F
Cancer Res; 1996 Jan; 56(2):362-9. PubMed ID: 8542593
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
[TBL] [Abstract][Full Text] [Related]
27. Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
Mackensen A; Carcelain G; Viel S; Raynal MC; Michalaki H; Triebel F; Bosq J; Hercend T
J Clin Invest; 1994 Apr; 93(4):1397-402. PubMed ID: 8163644
[TBL] [Abstract][Full Text] [Related]
28. In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes.
thor Straten P; Guldberg P; Grønbaek K; Hansen MR; Kirkin AF; Seremet T; Zeuthen J; Becker JC
J Immunol; 1999 Jul; 163(1):443-7. PubMed ID: 10384147
[TBL] [Abstract][Full Text] [Related]
29. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
Nishimura MI; Kawakami Y; Charmley P; O'Neil B; Shilyansky J; Yannelli JR; Rosenberg SA; Hood L
J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):85-94. PubMed ID: 7804531
[TBL] [Abstract][Full Text] [Related]
30. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
[TBL] [Abstract][Full Text] [Related]
31. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
[TBL] [Abstract][Full Text] [Related]
32. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M
Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313
[TBL] [Abstract][Full Text] [Related]
33. Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.
Bigler RD; Boselli CM; Foley B; Vonderheid EC
Am J Pathol; 1996 Nov; 149(5):1477-83. PubMed ID: 8909237
[TBL] [Abstract][Full Text] [Related]
34. T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy.
Willhauck M; Möhler T; Scheibenbogen C; Pawlita M; Brossart P; Schmier JW; Keilholz U
Clin Cancer Res; 1996 Apr; 2(4):767-72. PubMed ID: 9816229
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
Yazdi AS; Morstedt K; Puchta U; Ghoreschi K; Flaig MJ; Rocken M; Sander CA
J Invest Dermatol; 2006 Feb; 126(2):393-8. PubMed ID: 16374454
[TBL] [Abstract][Full Text] [Related]
36. Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.
Dufour E; Carcelain G; Gaudin C; Flament C; Avril MF; Faure F
J Immunol; 1997 Apr; 158(8):3787-95. PubMed ID: 9103444
[TBL] [Abstract][Full Text] [Related]
37. [T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions].
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1622-5. PubMed ID: 7574776
[TBL] [Abstract][Full Text] [Related]
38. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions.
Puisieux I; Bain C; Merrouche Y; Malacher P; Kourilsky P; Even J; Favrot M
Int J Cancer; 1996 Apr; 66(2):201-8. PubMed ID: 8603812
[TBL] [Abstract][Full Text] [Related]
39. Polyclonal uses of T-cell receptor (TCR)alpha and beta genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCR alpha in tumor-cell recognition.
Seito D; Morita T; Masuoka K; Maeda T; Saya H; Itoh K
Int J Cancer; 1994 Aug; 58(4):497-502. PubMed ID: 8056445
[TBL] [Abstract][Full Text] [Related]
40. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
